Match each cardiovascular medication used in the management of arrhythmias and other cardiac conditions with its most characteristic adverse effect profile.
- AmiodaronePulmonary toxicity, thyroid dysfunction, and hepatotoxicity
- ProcainamideDrug-induced lupus erythematosus with positive anti-histone antibodies
- AdenosineTransient atrioventricular block, flushing, and chest pain
- SotalolDose-dependent QT interval prolongation and torsades de pointes
- VerapamilConstipation, gingival hyperplasia, and negative inotropy
Answer
Amiodarone matches with pulmonary/thyroid/hepatic toxicity. Procainamide matches with drug-induced lupus. Adenosine matches with transient AV block/flushing. Sotalol matches with QT prolongation/torsades de pointes. Verapamil matches with constipation/gingival hyperplasia/negative inotropy.
Each cardiovascular medication has a unique, high-yield adverse effect profile that is heavily tested on the USMLE Step 2 CK. Amiodarone is famous for its wide-ranging tissue toxicities (lungs, liver, thyroid) due to its lipophilic nature and iodine content. Procainamide is a classic cause of drug-induced lupus. Adenosine administration is distinctly known for causing a brief period of asystole or AV block accompanied by severe flushing and chest discomfort. Sotalol carries a significant risk of QT prolongation leading to torsades de pointes. Verapamil's blockade of calcium channels commonly results in severe constipation and can depress cardiac contractility.
Step-by-Step Solution
Key Concept
Adverse effect profiles of cardiovascular medications (antiarrhythmics and calcium channel blockers).